Home » XENOMICS' PROPRIETARY MEDICAL DNA TECHNOLOGY DETAILED IN NEW EDITION OF LEADING TEXTBOOK ON ADVANCED MOLECULAR DIAGNOSTICS
XENOMICS' PROPRIETARY MEDICAL DNA TECHNOLOGY DETAILED IN NEW EDITION OF LEADING TEXTBOOK ON ADVANCED MOLECULAR DIAGNOSTICS
Xenomics, a developer of next-generation medical DNA technologies, announced
today that a team of company scientists has contributed a chapter about the
Xenomics' proprietary transrenal DNA technology platform in a new edition of
a leading scientific textbook about key advances and topics in the field of
modern molecular diagnostic advancements.
Business
Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May